Phase 1b Study of CAR2Anti-CEA CAR-T Cell Hepatic Infusions for Pancreatic Carcinoma Patients With CEA+ Liver Metastases
Clinical trial NCT03818165 · TERMINATED
Trial details
- NCT number
- NCT03818165
- Sponsor
- Sorrento Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-29
- Primary completion
- 2020-01-19
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.